4.5 Article

Detection of hypoxia in human brain tumor xenografts using a modified comet assay

Journal

NEOPLASIA
Volume 5, Issue 4, Pages 288-296

Publisher

NEOPLASIA PRESS
DOI: 10.1016/S1476-5586(03)80022-2

Keywords

hypoxia; comet assay; brain tumor cells; oxygen enhancement ratio; human tumor xenografts

Categories

Funding

  1. NCI NIH HHS [R01 CA085356, CA85356] Funding Source: Medline
  2. NINDS NIH HHS [NS47927] Funding Source: Medline

Ask authors/readers for more resources

We used the standard comet assay successfully to generate in vitro dose-response curves under oxic and hypoxic conditions. We then made mixtures of cells that had been irradiated with 3 and 9 Gy of X-rays to simulate two subpopulations in a tumor, but efforts to accurately detect and quantify the subpopulations using the standard comet assay were unsuccessful. Therefore, we investigated a modified comet assay to determine whether it could be used for measuring hypoxia in our model systems. U251 MG cells were grown as subcutaneous tumors in athymic mice; U251 MG and U87 MG cells were grown as intracerebral (i.c.) tumors in athymic rats. Animals were injected with RSU 1069, irradiated, and euthanized. Tumors and normal brains were removed, and the cells were analyzed using a modified comet assay. Differences in comet tail moment distributions between tumor and contralateral normal brain, using tail moments at either the 25th or 50th percentile in each distribution, were taken as measures of the degree of tumor hypoxia. For U251 MG tumors, there was a positive relationship between tumor size and the degree of hypoxia, whereas preliminary data from U87 MG i.c. tumors showed less hypoxia and no apparent relationship between tumor size and hypoxia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available